Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,733.68 +190.36 (+0.28%) CMC Crypto 200
1,427.14 -1.43 (-0.10%)
EyePoint Pharmaceuticals, Inc. (EYPT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 557.82M |
| Enterprise value | 263.10M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.16 |
| Price/book (mrq) | 2.23 |
| Enterprise value/revenue | 5.26 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.72 |
| 52-week change 3 | 77.32% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 30.99 |
| 52-week low 3 | 5.67 |
| 50-day moving average 3 | 16.78 |
| 200-day moving average 3 | 16.31 |
Share statistics
| Avg vol (3-month) 3 | 1.14M |
| Avg vol (10-day) 3 | 849.36k |
| Shares outstanding 5 | 52.08M |
| Implied shares outstanding 6 | 53.1M |
| Float 8 | 34.22M |
| % held by insiders 1 | 1.41% |
| % held by institutions 1 | 110.25% |
| Shares short (15 May 2024) 4 | 8.13M |
| Short ratio (15 May 2024) 4 | 4.88 |
| Short % of float (15 May 2024) 4 | 18.40% |
| Short % of shares outstanding (15 May 2024) 4 | 15.62% |
| Shares short (prior month 15 Apr 2024) 4 | 6.54M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 09 Dec 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 09 Dec 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -157.77% |
| Operating margin (ttm) | -285.19% |
Management effectiveness
| Return on assets (ttm) | -22.12% |
| Return on equity (ttm) | -48.07% |
Income statement
| Revenue (ttm) | 50.02M |
| Revenue per share (ttm) | 1.17 |
| Quarterly revenue growth (yoy) | 52.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -84.97M |
| Net income avi to common (ttm) | -78.92M |
| Diluted EPS (ttm) | -1.81 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 299.35M |
| Total cash per share (mrq) | 5.75 |
| Total debt (mrq) | 5.72M |
| Total debt/equity (mrq) | 2.29% |
| Current ratio (mrq) | 5.08 |
| Book value per share (mrq) | 5.01 |
Cash flow statement
| Operating cash flow (ttm) | -12.46M |
| Levered free cash flow (ttm) | 9.88M |
© 2024 Yahoo. All rights reserved.